Crow TJ: The two-syndrome concept: origins and current status. Schizophr Bull. 1985, 11: 471-486.
Article
CAS
PubMed
Google Scholar
Fenton WS, McGlashan TH: Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Arch Gen Psychiatry. 1991, 48: 969-977.
Article
CAS
PubMed
Google Scholar
Fenton WS, McGlashan TH: Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch Gen Psychiatry. 1991, 48: 978-986.
Article
CAS
PubMed
Google Scholar
Hoffmann H, Kupper Z: Relationships between social competence, psychopathology and work performance and their predictive value for vocational rehabilitation of schizophrenic outpatients. Schizophr Res. 1997, 23: 69-79.
Article
CAS
PubMed
Google Scholar
Moller HJ, Bottlender R, Wegner U, Wittmann J, Strauss A: Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand Suppl. 2000, 407: 54-57.
Article
PubMed
Google Scholar
Hoffmann H, Kupper Z: [Predictive factors of successful vocational re-integration in patients with chronic schizophrenia]. Psychiatr Prax. 2003, 30: 312-317.
Article
PubMed
Google Scholar
McGurk SR, Mueser KT, Harvey PD, LaPuglia R, Marder J: Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatr Serv. 2003, 54: 1129-1135.
Article
PubMed
Google Scholar
Wieselgren IM, Lindstrom E, Lindstrom LH: Symptoms at index admission as predictor for 1–5 year outcome in schizophrenia. Acta Psychiatr Scand. 1996, 94: 311-319.
Article
CAS
PubMed
Google Scholar
Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996, 153: 321-330.
Article
CAS
PubMed
Google Scholar
Umbricht DS, Wirshing WC, Wirshing DA, McMeniman M, Schooler NR, Marder SR, Kane JM: Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia. J Clin Psychiatry. 2002, 63: 420-424.
Article
PubMed
Google Scholar
Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl. 1989, 7: 49-58.
PubMed
Google Scholar
Andreasen NC: Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982, 39: 784-788.
Article
CAS
PubMed
Google Scholar
Christensen BK, Patrick RE, Stuss DT, Gillingham S, Zipursky RB: Verbal Episodic Memory Impairment in Schizophrenia: A Comparison with Frontal Lobe Lesion Patients. Clin Neuropsychol. 2013, 27 (4): 647-666.
Article
PubMed
Google Scholar
Goto M, Abe O, Miyati T, Yoshikawa T, Hayashi N, Takao H, Inano S, Kabasawa H, Mori H, Kunimatsu A, Aoki S, Ino K, Ida K, Yano K, Ohtomo K: Entorhinal cortex volume measured with 3 T MRI is positively correlated with the Wechsler Memory Scale-Revised logical/verbal memory score for healthy subjects. Neuroradiology. 2011, 53: 617-622.
Article
PubMed
Google Scholar
Wang CS, Yang YK, Chen M, Chiu NT, Yeh TL, Lee IH: Negative symptoms and regional cerebral blood flow in patients with schizophrenia: a single photon emission computed tomography study. Kaohsiung J Med Sci. 2003, 19: 464-469.
Article
PubMed
Google Scholar
Vaiva G, Thomas P, Llorca PM, Dupont S, Cottencin O, Devos P, Mazas O, Rascle C, Steinling M, Goudemand M: SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome. Psychiatry Res. 2002, 115: 37-48.
Article
CAS
PubMed
Google Scholar
Andreasen NC, Rezai K, Alliger R, Swayze VW, Flaum M, Kirchner P, Cohen B, O’Leary DS: Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry. 1992, 49: 943-958.
Article
CAS
PubMed
Google Scholar
Liddle PF, Friston KJ, Frith CD, Frackowiak RS: Cerebral blood flow and mental processes in schizophrenia. J R Soc Med. 1992, 85: 224-227.
CAS
PubMed
PubMed Central
Google Scholar
Botero S, Munoz CC, Ocampo MV, Escobar M, Rangel A, Quintero C, Marin C, Jaramillo LE, Sanchez R, Rodrigues-Losada R, Beltran D, Ospina J, Palacio C, Arango JCAquirre-Acevedo DC, Paez AL, Valencia AV, Garcia J: Verbal working memory in individuals with schizophrenia and their first degree relatives: relationship with negative and disorganized symptoms. Actas Esp Psiquiatr. 2013, 41: 106-114.
PubMed
Google Scholar
Ziauddeen H, Dibben C, Kipps C, Hodges JR, McKenna PJ: Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same?. Eur Arch Psychiatry Clin Neurosci. 2011, 261: 59-67.
Article
CAS
PubMed
Google Scholar
Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A: Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry. 2000, 57: 471-480.
Article
CAS
PubMed
Google Scholar
Schuepbach D, Keshavan MS, Kmiec JA, Sweeney JA: Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr Res. 2002, 53: 249-261.
Article
PubMed
Google Scholar
Liddle PF: Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med. 1987, 17: 49-57.
Article
CAS
PubMed
Google Scholar
Bagney A, Rodriguez-Jimenez R, Martinez-Gras I, Sanchez-Morla EM, Santos JL, Jimenez-Arriero MA, Lobo A, McGorry PD, Palomo T: Negative Symptoms and Executive Function in Schizophrenia: Does Their Relationship Change with Illness Duration?. Psychopathology. 2012, 46 (4): 241-248.
Article
PubMed
Google Scholar
Pelletier M, Achim AM, Montoya A, Lal S, Lepage M: Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis. Schizophr Res. 2005, 74: 233-252.
Article
PubMed
Google Scholar
Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG: Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res. 2004, 68: 1-9.
Article
PubMed
Google Scholar
Berman I, Viegner B, Merson A, Allan E, Pappas D, Green AI: Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res. 1997, 25: 1-10.
Article
CAS
PubMed
Google Scholar
Lee JS, Park HJ, Chun JW, Seok JH, Park IH, Park B, Kim JJ: Neuroanatomical correlates of trait anhedonia in patients with schizophrenia: a voxel-based morphometric study. Neurosci Lett. 2011, 489: 110-114.
Article
CAS
PubMed
Google Scholar
Roth RM, Flashman LA, Saykin AJ, McAllister TW, Vidaver R: Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. Am J Psychiatry. 2004, 161: 157-159.
Article
PubMed
Google Scholar
Benoit A, Bodnar M, Malla AK, Joober R, Lepage M: The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study. Front Psychiatry. 2012, 3: 42-
Article
PubMed
PubMed Central
Google Scholar
Ha TH, Youn T, Ha KS, Rho KS, Lee JM, Kim IY, Kim SI, Kwon JS: Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res. 2004, 132: 251-260.
Article
PubMed
Google Scholar
Baare WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS: Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry. 1999, 45: 1597-1605.
Article
CAS
PubMed
Google Scholar
Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, Yücel M, Velakoulis D, Pantelis C: Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res. 2011, 127: 46-57.
Article
PubMed
Google Scholar
Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A: Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001, 58: 148-157.
Article
CAS
PubMed
Google Scholar
Asami T, Whitford TJ, Bouix S, Dickey CC, Niznikiewicz M, Shenton ME, Vogelmaier MM, McCarley RW: Globally and locally reduced MRI gray matter volumes in neuroleptic-naive men with schizotypal personality disorder: association with negative symptoms. JAMA Psychiatry. 2013, 70: 361-372.
Article
PubMed
Google Scholar
Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ: Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev. 2012, 36: 1342-1356.
Article
PubMed
Google Scholar
Berge D, Carmona S, Rovira M, Bulbena A, Salgado P, Vilarroya O: Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects. Acta Psychiatr Scand. 2011, 123: 431-439.
Article
CAS
PubMed
Google Scholar
Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak RS, Dolan RJ: Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry. 2002, 159: 1497-1505.
Article
PubMed
Google Scholar
Talati A, Hirsch J: Functional specialization within the medial frontal gyrus for perceptual go/no-go decisions based on “what”, “when”, and “where” related information: an fMRI study. J Cogn Neurosci. 2005, 17: 981-993.
Article
PubMed
Google Scholar
Wolkin A, Choi SJ, Szilagyi S, Sanfilipo M, Rotrosen JP, Lim KO: Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am J Psychiatry. 2003, 160: 572-574.
Article
PubMed
Google Scholar
Kim JJ, Crespo-Facorro B, Andreasen NC, O’Leary DS, Magnotta V, Nopoulos P: Morphology of the lateral superior temporal gyrus in neuroleptic nai;ve patients with schizophrenia: relationship to symptoms. Schizophr Res. 2003, 60: 173-181.
PubMed
Google Scholar
Anderson JE, Wible CG, McCarley RW, Jakab M, Kasai K, Shenton ME: An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr Res. 2002, 58: 123-134.
Article
PubMed
PubMed Central
Google Scholar
Turetsky B, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE: Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry. 1995, 52: 1061-1070.
Article
CAS
PubMed
Google Scholar
Rajarethinam R, DeQuardo JR, Miedler J, Arndt S, Kirbat R, Brunberg JA, Tandon R: Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology. Psychiatry Res. 2001, 108: 79-87.
Article
CAS
PubMed
Google Scholar
Overall JE, Gorham DR: The brief psychiatric rating scale. Psychological reports. 1962, 89 (3): 259-268.
Google Scholar
Endicott J, Spitzer RL, Fleiss JL, Cohen J: The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976, 33: 766-771.
Article
CAS
PubMed
Google Scholar
PHILLIPS L: Case history data and prognosis in schizophrenia. J Nerv Ment Dis. 1953, 117: 515-525.
Article
CAS
PubMed
Google Scholar
Wechsler D: Wechsler Memory Scale. 1973, Psychological Corporation, New York
Google Scholar
Oswald WD: Das Nürnberger-Alters-Inventar. 1997, Hogrefe, Göttingen
Google Scholar
HAWIE-R: Hamburg-Wechsler- Intelligenztest für Erwachsene. Revision 1991; Handbuch und Testanweisung. 1991, Hans, Huber, Bern
Bäumler G: Farb-Wort-Interferenztest (FWIT) nach J.R. Stroop. 1985, Hogrefe, Göttingen
Google Scholar
Monchi O, Petrides M, Petre V, Worsley K, Dagher A: Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci. 2001, 21: 7733-7741.
CAS
PubMed
Google Scholar
Horn W: L-P-S Leistungsprüfsystem. 2.Auflage. 1983, Hogrefe, Göttingen
Google Scholar
Ugurbil K, Garwood M, Ellermann J, Hendrich K, Hinke R, Hu X, Kim SG, Menon R, Merkle H, Ogawa S: Imaging at high magnetic fields: initial experiences at 4 T. Magn Reson Q. 1993, 9: 259-277.
CAS
PubMed
Google Scholar
Lemieux L, Liu RS, Duncan JS: Hippocampal and cerebellar volumetry in serially acquired MRI volume scans. Magn Reson Imaging. 2000, 18: 1027-1033.
Article
CAS
PubMed
Google Scholar
Cendes F, Andermann F, Gloor P, Evans A, Jones-Gotman M, Watson C, Melanson D, Oliver A, Peters T, Lopes-Cendes I: MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology. 1993, 43: 719-725.
Article
CAS
PubMed
Google Scholar
Rusch N, Tebartz vE, Valerius G, Buchert M, Thiel T, Ebert D, Henning J, Olbrich HM: Neurochemical and structural correlates of executive dysfunction in schizophrenia. Schizophr Res. 2008, 99: 155-163.
Article
PubMed
Google Scholar
Tebartz VE, Baumer D, Ebert D, Trimble MR: Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia. Pharmacopsychiatry. 2004, 37: 217-220.
Article
Google Scholar
Hesslinger B, Thiel T, Tebartz VE, Hennig J, Ebert D: Attention-deficit disorder in adults with or without hyperactivity: where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy. Neurosci Lett. 2001, 304: 117-119.
Article
CAS
PubMed
Google Scholar
Tebartz vE, Woermann F, Lemieux L, Trimble MR: Increased amygdala volumes in female and depressed humans. A quantitative magnetic resonance imaging study. Neurosci Lett. 2000, 281: 103-106.
Article
Google Scholar
Tebartz vE, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Henning J, Ebert D: Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry. 2003, 54: 163-171.
Article
Google Scholar
Tebartz vE, Greenlee MW, Foley JM, Lucking CH: Contrast detection, discrimination and adaptation in patients with Parkinson’s disease and multiple system atrophy. Brain. 1997, 120 (Pt 12): 2219-2228.
Article
Google Scholar
Tebartz vE, Baeumer D, Lemieux L, Woermann FG, Koepp M, Krishnamoorthy S, Thompson PJ, Ebert D, Trimble MR: Amygdala pathology in psychosis of epilepsy: A magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain. 2002, 125: 140-149.
Article
Google Scholar
Tebartz vE, Woermann FG, Lemieux L, Trimble MR: Amygdala enlargement in dysthymia--a volumetric study of patients with temporal lobe epilepsy. Biol Psychiatry. 1999, 46: 1614-1623.
Article
Google Scholar
Aleman A, Hijman R, de Haan EH, Kahn RS: Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999, 156: 1358-1366.
CAS
PubMed
Google Scholar
Velligan DI, Bow-Thomas CC: Executive function in schizophrenia. Semin Clin Neuropsychiatry. 1999, 4: 24-33.
CAS
PubMed
Google Scholar
Hutton SB, Puri BK, Duncan LJ, Robbins TW, Barnes TR, Joyce EM: Executive function in first-episode schizophrenia. Psychol Med. 1998, 28: 463-473.
Article
CAS
PubMed
Google Scholar
Mattson DT, Berk M, Lucas MD: A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia. J Genet Psychol. 1997, 158: 487-494.
Article
CAS
PubMed
Google Scholar
Hill SK, Ragland JD, Gur RC, Gur RE: Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes. J Clin Exp Neuropsychol. 2002, 24: 765-780.
Article
PubMed
PubMed Central
Google Scholar
Vita A, De Peri L, Deste G, Sacchetti E: Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012, 2: e190-
Article
CAS
PubMed
PubMed Central
Google Scholar
Fujiwara H, Hirao K, Namiki C, Yamada M, Shimizu M, Fukuyama H, Hayashi T, Murai T: Anterior cingulate pathology and social cognition in schizophrenia: a study of gray matter, white matter and sulcal morphometry. Neuroimage. 2007, 36: 1236-1245.
Article
PubMed
Google Scholar
Noga JT, Aylward E, Barta PE, Pearlson GD: Cingulate gyrus in schizophrenic patients and normal volunteers. Psychiatry Res. 1995, 61: 201-208.
Article
CAS
PubMed
Google Scholar
Vita A, De Peri L, Silenzi C, Dieci M: Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res. 2006, 82: 75-88.
Article
CAS
PubMed
Google Scholar
Braff DL, Swerdlow NR: Neuroanatomy of schizophrenia. Schizophr Bull. 1997, 23: 509-512.
Article
CAS
PubMed
Google Scholar
Tebartz vE, Ebert D, Hesslinger B: Depression--augmentation or switch after initial SSRI treatment. N Engl J Med. 2006, 354: 2611-2613.
Article
Google Scholar
Itil T, Keskiner A, Kiremitci N, Holden JM: Effect of phencyclidine in chronic schizophrenics. Can Psychiatr Assoc J. 1967, 12: 209-212.
CAS
PubMed
Google Scholar
Murray JB: Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research. J Psychol. 2002, 136: 319-327.
Article
PubMed
Google Scholar
Luby E, Cohen BDRG, Gottlieb JS, Kelley R: Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry. 1959, 81: 363-369.
Article
CAS
PubMed
Google Scholar
Moller P, Husby R: The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophr Bull. 2000, 26: 217-232.
Article
CAS
PubMed
Google Scholar
Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993, 361: 31-39.
Article
CAS
PubMed
Google Scholar
Tsai G, Yang P, Chung LC, Lange N, Coyle JT: D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 1998, 44: 1081-1089.
Article
CAS
PubMed
Google Scholar
van Berkel PH, van Veen HA, Geerts ME, de Boer HA, Nuijens JH: Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem J. 1996, 319 (Pt 1): 117-122.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT: A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry. 1999, 56: 21-27.
Article
CAS
PubMed
Google Scholar